Login to Your Account

'Worst-Case Scenario': VaxGen Ends Planned Merger with Raven

By Jennifer Boggs

Monday, March 31, 2008
Despite attempts to quell grumblings from some of its stockholders over the last three months, troubled VaxGen Inc. ended its agreement to merge with Raven Biotechnologies, citing "stronger than anticipated" opposition to deal. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription